Patients with type 2 diabetes exhibit cognitive impairment with changes of metabolite concentration in the left hippocampus

Metabolic Brain Disease

Volumn 30, Issue 4, 2015, Pages 1027-1034

  Wang, Yue ^a   Xu, Xiao yun ^b   Feng, Chun hua ^a   Li, Yuan ling ^a   Ge, Xia ^a   Zong, Gen lin ^a   Wang, Yi bin ^a   Feng, Bo ^a   Zhang, Peng ^c  

^a TONGJI UNIVERSITY   (China)

^b Zhoupu Hospital of Pudong New Area   (China)

^c Pudong New Area Center for Disease Control and Prevention   (China)

Author keywords

Cognitive function; Metabolite; Proton magnetic resonance spectroscopy; Type 2 diabetes mellitus

Indexed keywords

CREATINE; INOSITOL;

ADULT; ARTICLE; ATTENTION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPTH PERCEPTION; EXECUTIVE FUNCTION; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; HUMAN; LANGUAGE ABILITY; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; NEUROCHEMISTRY; NEUROPSYCHOLOGICAL TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PROTON NUCLEAR MAGNETIC RESONANCE; RISK FACTOR; SINGLE VOXEL STIMULATED ECHO ACQUISITION MODE; WECHSLER MEMORY SCALE; AGED; CHINA; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY;

AGED; CHINA; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 84943359397     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-015-9670-4     Document Type: Article

References (27)

1. Bastos-Leite AJ, Kuijer JP, Rombouts SA, Sanz-Arigita E, van Straaten EC, Gouw AA, van der Flier WM, Scheltens P, Barkhof F (2008) Cerebral blood flow by using pulsed arterial spin-labeling in elderly subjects with white matter hyperintensities. AJNR Am J Neuroradiol 29(7): 1296-1301.
2. Biessels GJ, Deary IJ, Ryan CM (2008) Cognition and diabetes: a lifespan perspective. Lancet Neurol 7(2): 184-190.
3. Fisher SK, Novak JE, Agronoff BE (2002) Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J Neurochem 82(4): 736-754.
4. Gatto NM, Henderson VW, St John JA, McCleary C, Hodis HN, Mack WJ (2008) Metabolic syndrome and cognitive function in healthy middle-aged and older adults without diabetes. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 15(5): 627-641.
5. Gong YX (1989) Wechsler memory scale-revised in China. Hunan Medical University Publishing, Hunan [in Chinese].
6. Gujar SK, Maheshwari S, Björkman-Burtscher I, Sundgren PC (2005) Magnetic resonance spectroscopy. J Neuroophthalmol 25(3): 217-226.
7. Haley AP, Gonzales MM, Tarumi T, Miles SC, Goudarzi K, Tanaka H (2010) Elevated cerebral glutamate and myo-inositol levels in cognitively normal middle-aged adults with metabolic syndrome. Metab Brain Dis 25(4): 397-405.
8. Heikkilä O, Lundbom N, Timonen M, Groop PH, Heikkinen S, Mäkimattila S (2008) Risk for metabolic syndrome predisposes to alterations in the thalamic metabolism. Metab Brain Dis 23(3): 315-324.
9. HuangW, AlexanderGE, Chang L, Shetty HU, Krasuski JS, Rapoport SI, Schapiro MB (2001) Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1) H MRS study. Neurology 57(4): 626-632.
10. Jefferies E (2013) The neural basis of semantic cognition: converging evidence from neuropsychology, neuroimaging and TMS. Cortex 49(3): 611-625.
11. Li G, Xu X, Wang D, Wang J, Wang Y, Yu J (2011)Microglial activation during acute cerebral infarction in the presence of diabetes mellitus. Neurol Sci 32(6): 1075-1079.
12. Modi S, Bhattacharya M, Sekhri T, Rana P, Tripathi RP, Khushu S (2008) Assessment of the metabolic profile in type 2 diabetes mellitus and hypothyroidism through proton MR spectroscopy. Magn Reson Imaging 26(3): 420-425.
13. Moffett JR, Ross B, Arun P, Madhavarao CN, NamboodiriAM (2007) Nacetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 81(2): 89-131.
14. Musen G, Lyoo IK, Sparks CR, Weinger K, Hwang J, Ryan CM, Jimerson DC, Hennen J, Renshaw PF, Jacobson AM (2006) Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 55(2): 326-333.
15. Park CR (2001) Cognitive effects of insulin in the central nervous system. Neurosci Biobehav Rev 25(4): 311-323.
16. Ross B, Bluml S (2001) Magnetic resonance spectroscopy of the human brain. Anat Rec 265(2): 54-84.
17. Ross AJ, Sachdev PS (2004) Magnetic resonance spectroscopy in cognitive research. Brain Res Rev 44(2-3): 83-102.
18. Sahin I, Alkan A, Keskin L, Cikim A, Karakas HM, Firat AK, Sigirci A (2008) Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus. J Diabetes Complicat 22(4): 254-260.
19. Sarac K, Akinci A, Alkan A, Aslan M, Baysal T, Ozcan C (2005) Brain metabolite changes on proton magnetic resonance spectroscopy in children with poorly controlled type 1 diabetes mellitus. Neuroradiology 47(7): 562-565.
20. Schaefer M, Heinze HJ, Rotte M (2006) Verbal memory encoding in patients with left-sided hippocampal sclerosis. Neuroreport 17(11): 1219-1223.
21. Smith EE, Jonides J (1999) Storage and executive processes in the frontal lobes. Science 283(5408): 1657-1661.
22. van der Graaf M, Janssen SW, van Asten JJ, Hermus AR, Sweep CG, Pikkemaat JA, Martens GJ, Heerschap A (2004) Metabolic profile of the hippocampus of Zucker Diabetic Fatty rats assessed by in vivo 1H magnetic resonance spectroscopy. NMR Biomed 17(6): 405-410.
23. van Harten B, de Leeuw FE, Weinstein HC, Scheltens P, Biessels GJ (2006) Brain imaging in patients with diabetes: a systematic review. Diabetes Care 29(11): 2539-2548.
24. Vrenken H, Barkhof F, Uitdehaag BM, Castelijns JA, Polman CH, Pouwels PJ (2005) MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter. Magn Reson Med 53(2): 256-266.
25. Watanabe T, Shiino A, Akiguchi I (2012) Hippocampal metabolites and memory performances in patients with amnestic mild cognitive impairment and Alzheimer's disease. Neurobiol Learn Mem 97(3): 289-293.
26. Wessels AM, Simsek S, Remijnse PL, Veltman DJ, Biessels GJ, Barkhof F, Scheltens P, Snoek FJ, Heine RJ, Rombouts SA (2006) Voxelbased morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia 49(10): 2474-2480.
27. Yaffe K, Weston AL, Blackwell T, Krueger KA (2009) The metabolic syndrome and development of cognitive impairment among older women. Arch Neurol 66(3): 324-328.